Having trouble accessing articles? Reset your cache.

Figitumumab: Phase I/II data

Data from 107 patients enrolled in the Phase II portion of an open-label, international Phase I/II trial showed that

Read the full 198 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE